🔓
Sign in as a Member to unlock the full view of ASND. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
ASND

Ascendis Pharma A/S

Sector: healthcareBiotechnologyNASDAQMarket Cap: $13.81B

Ascendis Pharma A/S is a biopharmaceutical company focused on endocrinology and rare diseases, with its primary political exposure stemming from eight pending healthcare bills each estimated to impact revenue by ~$5M.

Next filing → your inbox
Govt Dependence
85/100
Regulatory Density
90/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat ASND does

Ascendis Pharma A/S is a late-stage biopharmaceutical company developing product candidates for rare endocrine diseases and endocrine-related cancers using its TransCon technology platform. Its commercial portfolio includes treatments for growth hormone deficiency and hypoparathyroidism, with revenue derived from product sales and collaboration agreements. The company's pipeline is heavily dependent on FDA regulatory pathways and reimbursement policies.

12 months past · 3 months futureASND activity timeline

$285$238$191 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $277.18 hi $196.63 lo $271.73 CONGRESS 6 INSIDERS 2 13F FUNDS 30 BILLS 30 BIENAIME JEAN JACQUES · · BUY 2026-08-14BIENAIME JEAN JACQUES · · BUY 2026-08-14 Citadel Advisors · + $108M · 2026-06-30Citadel Advisors · + $106M · 2025-12-31Millennium Management · + $88M · 2026-06-30Two Sigma Investments · + $82M · 2026-06-30Point72 Asset Management · OPENED $70M · 2026-03-31Millennium Management · - $56M · 2025-12-31Two Sigma Investments · + $53M · 2025-12-31Two Sigma Investments · - $52M · 2026-03-31Millennium Management · - $43M · 2026-03-31Renaissance Technologies · holds $32M · 2026-06-30Renaissance Technologies · OPENED $27M · 2026-03-31D.E. Shaw & Co. · + $26M · 2025-12-31Renaissance Technologies · - $22M · 2026-09-30 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 0 congressional trades shown · 2 insider buys · 13 13F filings · 1 past bill actions · 5 upcoming markups

Lifetime Government AwardsASND federal contracts

ASND doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding ASND

$316.4M
Total ASND held by tracked 13F funds
5
Funds with ASND positions
Citadel Advisors $108M +502% 2026-06-30
Millennium Management $88M +74% 2026-06-30
Two Sigma Investments $82M +36% 2026-06-30
Renaissance Technologies $22M -20% 2026-09-30
D.E. Shaw & Co. $17M +27% 2026-06-30

Congressional TradesWho in Congress is trading ASND

2018-10-05 Gary J. Palmer R-Alabama · house sale $1,001 - $15,000
2018-10-05 Gary J. Palmer R-Alabama · house Sale $1,001 - $15,000
2018-07-12 Gary J. Palmer R-Alabama · house purchase $1,001 - $15,000 79d late
2018-08-06 Gary J. Palmer R-Alabama · house purchase $1,001 - $15,000 54d late
2018-07-12 Gary J. Palmer R-Alabama · house Purchase $1,001 - $15,000 79d late
2018-08-06 Gary J. Palmer R-Alabama · house Purchase $1,001 - $15,000 54d late
6+ trades on file · most recent 2018-11-07

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Open-market buys

C
Insider signal score 40/100 · 1 distinct insiders · 2 open-market buys totaling $493K in the last 180 days.
2026-08-14 BIENAIME JEAN JACQUES BUY 1,100 sh $270K

Stock awards & option exercises

1
option exercises · $330K
For ASND, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting ASNDLive legislation impacting this stock

Political ProfileWhere ASND sits in Washington

[object Object]

STRUCTURAL: High regulatory density (score 90) and government dependence (score 85) due to healthcare sector and pending legislation. EVIDENTIARY: No direct political engagement: $0 lobbying (`get_political_influence.lobbying.total_income`), 0 corporate insider buys (`get_corporate_insider_signal.total_buys`), 0 congressional traders (`Top congressional traders`), and $0 federal contracts (`get_government_precedent.federal_contracts_summary`). Net: High structural exposure is entirely unmitigated by evidentiary support, creating a neutral but fragile signal.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Potential revenue impact from multiple pending healthcare bills affecting drug pricing or market access.
    Congress
    "`Recent bill_impacts` lists eight bills with uniform impact_ratio of 0.0004 and estimated revenue impacts averaging ~$5.1M."

Regulatory opportunities

  • Legislative action could standardize or expedite reimbursement for rare disease therapies.
    Congress
    "`Recent bill_impacts` indicates multiple bills in the healthcare sector directly modeling revenue impact for the company."
Member intelligence layer

Live signals + predictions for ASND — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout ASND & political exposure

Does Ascendis Pharma A/S (ASND) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Ascendis Pharma A/S. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded ASND stock?
6 congressional trades by 1 unique members of Congress, most recently on 2018-10-05. See the Congressional Trading panel for politician-by-politician breakdown.
What is ASND political risk profile?
Government dependence: 85/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track ASND political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ASND data is updated daily from these official federal sources.